MiR-1294 acts as a tumor inhibitor in cervical cancer by regulating FLOT1 expression

XQ. Kan, YB. Li, B. He, SF. Cheng, YJ. Wei, JL. Sun

Article ID: 4687
Vol 34, Issue 2, 2020
DOI: https://doi.org/10.23812/20-10A
Received: 9 May 2020; Accepted: 9 May 2020; Available online: 9 May 2020; Issue release: 9 May 2020

Abstract

Recently, important regulatory mechanisms of microRNAs (miRNAs) have been widely reported in human cancers including cervical cancer. The purpose of this study is to preliminarily clarify the function of miR-1294 in cervical cancer. The expression of miR-1294 or FLOT1 was detected using RT-qPCR or Western blot analysis. MTT, Transwell and luciferase reporter assays were used to explore the functional mechanism of miR-1294. The results showed that miR-1294 expression was decreased in cervical cancer. Functionally, overexpression of miR-1294 restrained the viability and metastasis of cervical cancer cells. MiR-1294 can also block EMT and suppress β-catenin expression in cervical cancer cells. Additionally, FLOT1 was confirmed to be a direct target of miR-1294. The knockdown of FLOT1 impeded the progression of cervical cancer. More importantly, miR-1294 inhibited the occurrence of cervical cancer by interacting with FLOT1. In conclusion, miR-1294 inhibits cell viability, migration and invasion by suppressing FLOT1 expression.


Keywords

FLOT1;cervical cancer;metastasis;miR-1294;viability


References

Supporting Agencies



Copyright (c) 2020 XQ. Kan, YB. Li, B. He, SF. Cheng, YJ. Wei, JL. Sun




This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).